PBM execs face House grilling

By The Hill | Jul 22, 2024 at 06:34 PM EST

Executives from major PBMs will testify before the House Oversight Committee on the impact of PBMs on prescription drug costs. Bipartisan pressure is mounting for reforms due to concerns over pricing practices. The hearing aims to address anticompetitive tactics and potential reforms to lower drug prices.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.